期刊
ONCOLOGY REPORTS
卷 39, 期 6, 页码 2777-2786出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2018.6339
关键词
retinoblastoma; corosolic acid; cell cycle arrest; cell apoptosis; MELK-FoxM1 signaling
类别
资金
- National Significant New Drugs Creation Program [2017ZX09304021]
- Jiangsu Provincial Medical Innovation Team [CXTDA2017024]
- Major Project of Wuxi Municipal Health Bureau [ZS201401, Z201508]
- Project of Wuxi Municipal Science and Technology Bureau [CSE31N1520, CSE31N1621]
Retinoblastoma (Rb) is the most frequent primary intraocular tumor usually diagnosed in infants and children, and current therapy for such disease is still limited. Corosolic acid (CA), an ursane-type pentacyclic triterpene, has been assessed as a promising anticancer agent with little impact on untransformed cells. In the present study, we investigated the cytotoxic effect and underlying mechanism of CA on human retinoblastoma Y-79 cells. The viability of cells was verified by MTT assay. Cell cycle and apoptosis were evaluated by flow cytometric analysis. The expressions and activities of the related molecules were assessed by western blot analysis and luciferase assay. The results demonstrated that the treatment of CA dose-dependently induced cytotoxicity, cell cycle arrest and cell apoptosis in Y-79 cells. Furthermore, MELK-FoxM1 signaling was estimated to be involved in the cytotoxic effect of CA on Y-79 cells, and CA exerted its activity mainly through inhibition of the expression levels of MELK and FoxM1 as well as through suppression of the transcriptional activity of FoxM1 driven by itself or MELK. Our findings establish MELK-FoxM1 signaling as a promising therapeutic target for human retinoblastoma, and suggest the potential development of CA and its derivatives as novel drug candidates against this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据